BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34439769)

  • 1. Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review.
    Chen Y; Wang X; Guan L; Wang Y
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
    Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
    Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
    Rane S; Owen J; Hippe DS; Cholerton B; Zabetian CP; Montine T; Grabowski TJ
    J Neuroimaging; 2020 Nov; 30(6):843-850. PubMed ID: 32937003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions.
    Weaver NA; Doeven T; Barkhof F; Biesbroek JM; Groeneveld ON; Kuijf HJ; Prins ND; Scheltens P; Teunissen CE; van der Flier WM; Biessels GJ;
    Neurobiol Aging; 2019 Dec; 84():225-234. PubMed ID: 31500909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.
    Park M; Moon Y; Han SH; Kim HK; Moon WJ
    Eur Radiol; 2019 Sep; 29(9):4914-4921. PubMed ID: 30488109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
    Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
    [No Abstract]   [Full Text] [Related]  

  • 8. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    van den Berg E; Geerlings MI; Biessels GJ; Nederkoorn PJ; Kloppenborg RP
    J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral white matter Hyperintensities in HIV-positive patients.
    Trentalange A; Prochet A; Imperiale D; Cusato J; Tettoni M; Nunnari G; Barco A; Bonora S; Di Perri G; Calcagno A
    Brain Imaging Behav; 2020 Feb; 14(1):10-18. PubMed ID: 30238207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid β-amyloid
    Osborn KE; Liu D; Samuels LR; Moore EE; Cambronero FE; Acosta LMY; Bell SP; Babicz MA; Gordon EA; Pechman KR; Davis LT; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
    Neurobiol Aging; 2018 Aug; 68():18-25. PubMed ID: 29702372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.
    Alber J; Alladi S; Bae HJ; Barton DA; Beckett LA; Bell JM; Berman SE; Biessels GJ; Black SE; Bos I; Bowman GL; Brai E; Brickman AM; Callahan BL; Corriveau RA; Fossati S; Gottesman RF; Gustafson DR; Hachinski V; Hayden KM; Helman AM; Hughes TM; Isaacs JD; Jefferson AL; Johnson SC; Kapasi A; Kern S; Kwon JC; Kukolja J; Lee A; Lockhart SN; Murray A; Osborn KE; Power MC; Price BR; Rhodius-Meester HFM; Rondeau JA; Rosen AC; Rosene DL; Schneider JA; Scholtzova H; Shaaban CE; Silva NCBS; Snyder HM; Swardfager W; Troen AM; van Veluw SJ; Vemuri P; Wallin A; Wellington C; Wilcock DM; Xie SX; Hainsworth AH
    Alzheimers Dement (N Y); 2019; 5():107-117. PubMed ID: 31011621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.
    Hu HY; Ou YN; Shen XN; Qu Y; Ma YH; Wang ZT; Dong Q; Tan L; Yu JT
    Neurosci Biobehav Rev; 2021 Jan; 120():16-27. PubMed ID: 33188821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
    J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.
    Wardlaw JM; Valdés Hernández MC; Muñoz-Maniega S
    J Am Heart Assoc; 2015 Jun; 4(6):001140. PubMed ID: 26104658
    [No Abstract]   [Full Text] [Related]  

  • 17. White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    van Waalwijk van Doorn LJC; Ghafoorian M; van Leijsen EMC; Claassen JAHR; Arighi A; Bozzali M; Cannas J; Cavedo E; Eusebi P; Farotti L; Fenoglio C; Fortea J; Frisoni GB; Galimberti D; Greco V; Herukka SK; Liu Y; Lleó A; de Mendonça A; Nobili FM; Parnetti L; Picco A; Pikkarainen M; Salvadori N; Scarpini E; Soininen H; Tarducci R; Urbani A; Vilaplana E; Meulenbroek O; Platel B; Verbeek MM; Kuiperij HB
    J Alzheimers Dis; 2021; 79(1):163-175. PubMed ID: 33252070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities are associated with falls in older people with dementia.
    Taylor ME; Lord SR; Delbaere K; Wen W; Jiang J; Brodaty H; Kurrle SE; Stefanie Mikolaizak A; Close JCT
    Brain Imaging Behav; 2019 Oct; 13(5):1265-1272. PubMed ID: 30145714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered dynamic functional network connectivity and topological organization variance in patients with white matter hyperintensities.
    Huang C; Zhou X; Ren M; Zhang W; Wan K; Yin J; Li M; Li Z; Zhu X; Sun Z
    J Neurosci Res; 2023 Nov; 101(11):1711-1727. PubMed ID: 37469210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Functional Connectivity Patterns of Parietal Subregions Contribute to Cognitive Dysfunction in Patients with White Matter Hyperintensities.
    Wei Q; Cao S; Ji Y; Zhang J; Chen C; Wang X; Tian Y; Qiu B; Wang K
    J Alzheimers Dis; 2021; 84(2):659-669. PubMed ID: 34569947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.